News

People with a blistering skin disease called dystrophic epidermolysis bullosa often suffer from large open wounds that last for years or decades. A double-blind, placebo-controlled clinical trial of a gene therapy gel developed at Stanford Medicine shows improved wound healing in people with the disease.

Degus – long-lived Chilean rodents – have been shown to be a useful and practical model of Alzheimer's disease.

Scientists have discovered that Interleukin-37 has an unexpected function as an immune-activating molecule, rather than an "off-switch" as once believed.

A combination of a common immunotherapy drug with all-trans retinoic acid, a chemotherapeutic, has shown promise in clinical trials.

Scientists at Dana-Farber Cancer Institute identify, for the first time, inherited genetic variations that place patients at high risk for adverse effects associated with immunotherapy.

According to research, adding cranberry extract to lipstick can inactivate disease-causing viruses, bacteria and a fungus that come in contact with it.

A new study has demonstrated a promising experimental therapy in preclinical models of an aggressive subtype of colorectal cancer.

Researchers have tested three different treatment approaches theorized to slow the rate of aging, and found all to be ineffective in mice.

In a murine study, it was found that medicines usually used to treat angina and high blood pressure prevented much of the long-term damage caused by acute kidney injury.

A new study from Weill Cornell Medicine has noted that the long-term immune response to the SARS-CoV-2 mRNA vaccine is similar in pregnant and non-pregnant individuals.